| Code | CSB-MP012474HU1 |
| Abbreviation | Recombinant Human KLRK1 protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
NKG2-D (KLRK1) is a key activating receptor in NK cell and CD8+ T cell immunosurveillance, making its ligand-binding interactions a critical target in immuno-oncology drug discovery. This recombinant human KLRK1 encompasses the extracellular ligand-binding domain (aa 78–216), expressed in mammalian cells with a C-terminal hFc1 tag to preserve native glycosylation and conformational integrity essential for receptor-ligand recognition. Functional ELISA confirms robust binding to human ULBP1 with an EC50 of 222.4–276.0 ng/ml, providing validated support for ligand-interaction assays, competitive inhibition studies, blocking antibody screening, and affinity characterization by SPR or BLI. Purity exceeding 90% by SDS-PAGE combined with endotoxin levels below 1.0 EU/μg satisfies the quality thresholds commonly required for therapeutic antibody epitope mapping and small-molecule inhibitor screening in cancer immunology research.
Applications : Binding assay/Protein-protein interaction
Review: We purchased two products at the same time, ULBP1 protein (CSB-MP887177HU) and KLRK1 protein (CSB-MP012474HU1), for ELISA experiment verification. The EC50 was 228.5-427.6 ng/ml, and these two had good binding activity. The protein purity was also very high, and the repeatability was good, which can be used for subsequent protein interaction research experiments.
By Anonymous